Ars Pharmaceuticals Inc (SPRY)

Finanzdaten der Ars Pharmaceuticals Inc-Aktie (SPRY)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	48.40%33.66	22.68	28.09	32.50	15.72
	14.85%95.12	82.83	69.55	85.69	63.33
Selling, General, and Administrative	7.44%77.58	72.20	59.96	74.75	54.31
Research and Development	8.35%4.70	4.34	3.44	2.75	4.04
Depreciation and Amortization	4.79%0.42	0.40	0.42	0.39	0.28
Operating Income/Loss	2.19%-61.47	-60.15	-41.47	-53.19	-47.61
	2.84%-62.34	-60.62	-41.32	-51.15	-44.88
Attributable To Parent	2.84%-62.34	-60.62	-41.32	-51.15	-44.88
Basic Average Shares	0.02%99.31	99.30	0.15	98.81	98.36
Diluted Average Shares	0.02%99.31	99.30	0.15	98.81	98.36
Basic Earnings Per Share	3.28%-0.63	-0.61	-0.42	-0.52	-0.46
Diluted Earnings Per Share	3.28%-0.63	-0.61	-0.42	-0.52	-0.46